Skip to main content

“Maybe if I stop the drugs, then maybe they’d care?”—hospital care experiences of people who use drugs



Drug use is associated with increased morbidity and mortality but people who use drugs experience significant barriers to care. Data are needed about the care experiences of people who use drugs to inform interventions and quality improvement initiatives. The objective of this study is to describe and characterize the experience of acute care for people who use drugs.


We conducted a qualitative descriptive study. We recruited people with a history of active drug use at the time of an admission to an acute care hospital, who were living with HIV or hepatitis C, in Toronto and Ottawa, Canada. Data were collected in 2014 and 2015 through semi-structured interviews, audio-recorded and transcribed, and analyzed thematically.


Twenty-four adults (18 men, 6 women) participated. Participants predominantly recounted experiences of stigma and challenges accessing care. We present the identified themes in two overarching domains of interest: perceived effect of drug use on hospital care and impact of care experiences on future healthcare interactions. Participants described significant barriers to pain management, often resulting in inconsistent and inadequate pain management. They described various strategies to navigate access and receipt of healthcare from being “an easy patient” to self-advocacy. Negative experiences influenced their willingness to seek care, often resulting in delayed care seeking and targeting of certain hospitals.


Drug use was experienced as a barrier at all stages of hospital care. Interventions to decrease stigma and improve our consistency and approach to pain management are necessary to improve the quality of care and care experiences of those who use drugs.


In 2010, mental and substance use disorders were estimated to account for 22.9% of years lived with disability (YLDs) worldwide and 7.4% of all disability-adjusted life years (DALYs) [1], with drug use disorders directly accounting for 0.8% of the total DALYs worldwide [2]. While the Global Burden of Disease Study 2015 shows an overall global improvement in health between 2005 and 2015, the disability-adjusted life years associated with drug use disorders increased by more than 20% [3]. As such, illicit drug use has been identified as an important contributor to the global burden of disease [2], with Canada among the countries with a significantly higher (than the global mean) burden. People who use drugs (PWUD) are at risk of drug-related harms (e.g., infections, overdose, and death) [4,5,6,7] and greater risk of acquiring HIV, hepatitis B, and hepatitis C and co-infections for people who inject drugs [8,9,10].

PWUD are more likely than others to present in the emergency department [11,12,13,14], present at a later stage of illness if living with HIV [15, 16], and be admitted to hospital [17]. However, despite their complex health challenges, they face significant barriers to accessing and receiving equitable care [18] including healthcare provider stigma, inadequate pain management, and organizational factors including requirements for abstinence. Stigma related to drug use, in terms of the internalized stigma, blame, and sense of difference felt by PWUD and the stigmatization and discriminatory actions towards PWUD, may strongly impact individual’s feelings of worth and their interactions with the general public and professionals, including those in healthcare settings [19, 20]. Consequently, stigma may impact all relevant healthcare experiences and outcomes of PWUD, directly or indirectly, whether it is identified or not. PWUD have reported poor access to healthcare, and that their care was inferior to the care received by non-users [21]. When admitted to hospital, PWUD are sometimes labelled “challenging, manipulative, drug-seeking, and demanding” by healthcare workers who are not prepared, trained, or willing to meet their needs [22,23,24]. People who use drugs are also more likely to be discharged against medical advice [25,26,27,28]. A recent study of people who inject drugs in Vancouver, Canada, found the hospital to be a “risk environment” wherein social and structural factors contributed to participants experiencing inadequate pain and withdrawal management, consequent drug use, and increased likelihood of discharge against medical advice [29].

There is strong evidence to support the need for improved access, care, and continuity of services for PWUD; however, little focus is placed on their lived experience of receiving hospital care. Understanding the experience of accessing, negotiating, and receiving care in the hospital environment is critical to informing interventions to improve health outcomes in PWUD and quality improvement initiatives. To address this gap, we conducted a descriptive qualitative study characterizing the experience of hospital care for PWUD living with HIV and/or hepatitis C. We focused on people living with HIV and hepatitis C (HCV) because these individuals, in addition to experiencing higher rates of substance dependency, are more frequent users of hospitals and may require complex and extended care [30,31,32]. This population provides the opportunity to explore the experiences of people who use drugs and who have frequent interactions with healthcare providers and health systems.


This qualitative descriptive study [33, 34] is situated in a larger program of research about the care needs of people who use drugs during hospital admissions and the role of harm reduction [35, 36]. A purposive sampling strategy was used to recruit people living with HIV and/or HCV who self-identified as using drugs and had received in-patient hospital care in the past year. Participants were recruited from the large urban centers of Ottawa and Toronto, which have concentrations of people living with HIV and HCV, people who use drugs, and large hospital networks. The study was advertised through paper and electronic advertisements at local AIDS service organizations and an HIV specialty hospital providing care to this population, and through word of mouth. The impetus for this research study emerged through conversations with members of our research program’s community advisory groups in Toronto and Ottawa. These groups provided feedback and guidance on the project from start to finish [37]. Members of these advisory groups who met the inclusion criteria for the study were eligible to participate. The study received ethical approval from the University of Toronto HIV Research Ethics Board. Participants provided written consent and were compensated for their time ($25 CAD and return transit fare).

Interviews were conducted in-person in a private room at the community organizations where recruiting occurred. Participants were asked to complete a questionnaire with demographic measures, such as age, race/ethnicity, and gender, as well as current housing, perceived physical and mental health status, drugs consumed over their lifetime and within the previous 3 months, and to rate their most recent experience receiving care in hospital. Participants were interviewed using semi-structured guides which explored their in-hospital experiences including key issues related to accessing care, the strategies used to negotiate/manage their drug use in an in-patient setting, how they perceived drug use to influence the provision of care and therapeutic relationships, and what policies and practices might ensure care is appropriate to their needs. Interviews lasted between 10 min and 1 h and were conducted between December 2014 and May 2015.


All interviews were audio-recorded, anonymized, and transcribed verbatim. We verified and uploaded all interview transcripts to NVivo 11 qualitative data management software. We used a thematic analysis approach, using a primarily realist perspective [38] to describe and explore the hospital experiences of this population, with the ultimate goal of understanding what components of hospital care “work”, and why, for engaging PWUD in healthcare to ultimately improve their health [39]. Following initial coding, we moved towards establishing the relationship between codes and identifying themes. We used several strategies to enhance analytical rigor. Themes were reviewed and discussed in team meetings (AG, SCC, CS). We conducted member checks with our community advisory committees to ensure our interpretation resonated and to plan next stages in the research [40]. We entered all questionnaire data into Excel and report results for categorical variables with frequencies and proportions.


We conducted 24 interviews with PWUD and living with HIV and/or hepatitis C in Ottawa (n = 12) and Toronto (n = 12), Canada. Participant characteristics are summarized in Table 1. All but two participants were living with HIV; 11 (46%) were co-infected with HIV and HCV. Twelve participants (50%) had some form of paid employment in the last 12 months. The most common drugs used in the last 3 months, other than cannabis (83%), were cocaine (62%), non-prescribed use of prescription opioids (50%), non-prescribed use of sedatives (38%), and methamphetamines (33%).

Table 1 Participant characteristics

Participants described diverse experiences of care. They often stated that their experiences were not all bad; however, probes regarding positive experiences did not yield specific details and usually suggested or explicitly stated that “good” experiences were defined as a lack of negative experiences. For example, when one participant was asked why he defined his last admission as relatively good, he responded “Nobody was criticizing me or giving me a hard time.” (P-41). Participants focused most predominantly on instances of stigma and challenges accessing adequate and appropriate care, which they predominantly saw as manifestations of stigma associated with presumed drug use. We present our findings in two overarching domains of interest: perceived effect of drug use on hospital care and impact of care experiences on future healthcare interactions. These topics are not distinct. The first focuses generally on the care experience from the point of initial presentation to the time of hospital discharge during which the experience of accessing and receiving pain management emerged as an especially prominent theme. The second domain captures the impact and response of the participants to the care received, addressing the dynamic nature of engaging in care in hospital and the recursivity and impact on health seeking in the future.

Perceived effect of drug use on hospital care

Participants did not identify all hospital experiences as negative, but clearly identified instances where drug use had negatively impacted their care experiences at all stages of the process, from deciding to seek care through to discharge from hospital. They felt drug use, or presumed drug use, strongly influenced the attitudes and relationships with clinicians, access and timeliness of care, and physicians’ adjudication and resulting offers to prescribe certain medications, most importantly those for pain management.

Feelings of stigma and discrimination by clinicians

Participants spoke about the stigma they felt and the discrimination they experienced from clinicians. Stigma was felt to influence how hospital staff engaged with, and spoke to, patients when drug use was known or suspected, and participants identified negative experiences as examples of discrimination.

In general, they tend to be a little stricter with you. They tend to be more short tempered with you. They tend to presume what you need, instead of a conversation, right? … And they do not actually get to know the person. (P-22)

…they have no respect for you, do not know what to do with you and do not really want to bother. (P-41)

Like, it’s a stereotype, the way some of the doctors and nurses will treat you. They have their own diagnosis of you, and if there’s drugs involved, your diagnosis is done. They do not need to look further, that’s it; that’s all. (P-42)

Participants recounted clinicians speaking negatively about them directly and to other staff or patients.

The doctor …did not know that I understood French. Right? So he says to the nurse that he’s tired of work[ing] with these type of junkie people. He wished that they did not even come to the hospital. (P-15)

I know of dozens of doctors who are terrific, but I know probably tenfold more doctors that are mean and judgmental, and negligent, and it’s not just physicians. You know, I had a nurse in the [hospital] the first week or two after my surgery that was reaming me out because I was an alcoholic and I was taking up a bed, because that’s how I got my cancer. (P-23)

One woman recounted a particularly negative experience. She presented in the emergency department (ED) to seek care following a drug deal which became violent:

And the nurse, I call her nurse Ratchet. She was horrible. She said to me, if I do not submit to this rape kit thing, that I should just leave and this bed be given to someone who needs it. And it was wintertime, and I had one shoe, and bare feet [in] the other foot. And I did not have a coat, and my clothes were torn. And you know, I left the hospital and she was just such a horrible… nurse. (P-19)

Challenges accessing care and timeliness of care

Participants felt that clinicians’ awareness of their past or current drug use, and associated stigmas, not only impacted how clinicians spoke and interacted with them (as discussed above) but negatively impacted the attentiveness and timeliness of their care in the ED and once admitted. Although individual events in EDs are described below, they reflect a common theme across participant experiences: perceived stigmatizing and discriminatory behavior of staff including delayed assessment and treatment. One participant described an experience in the ED with his partner: “…we were treated completely like ‘Put them over there in the corner. They’re drug users.’ And so that was, like, zero respect.” He explained that it was later discovered his partner had pneumonia and was in hospital for over 3 weeks. He spoke about his frustration and efforts to get attention:

They put us in a room way far at the back (laugh) of the [ED]. And, we did not see anybody. He actually stopped breathing a couple of times, and I ran out and I said …. ‘If anybody cares, the drug addict in the back here, may be dying.’ Cause I was just so incensed. …the second time, security did come and say ‘If this happens again, we are going to have to ask you to leave.’ (P-38)

Another participant described his fear of an ED, associated with delayed attention.

… I’d be afraid to go [to a specific hospital] if I could not breathe with my asthma. They’ll think it was something else, I do not know, and I’d probably die, so … I think they suspect that people are drug seeking right? And then they do not bother seeing if you are okay. (P-27)

This participant recounted a story of sneaking out of a back-assessment room of the ED and taking a cab to another hospital “Mainly because I was afraid I was going to die, right? So they just left me in a room, and I was like, ‘I’m out of here. So out of here.’” (P-27)

One participant recounted going to the ED with a ruptured spleen and how he had to scream in pain for some time before he was seen, identifying this as discrimination because of presumed drug dependence: “it was pretty clear to me that they really did think, you know, ‘Oh, it’s just, oh, just looking to get some painkillers.’” (P-29)

In addition to challenges faced in the ED, some participants believed that once admitted their needs were addressed more slowly than those of fellow patients.

They treat you differently because you are, when you are on the HIV ward, they treat you differently. And you are a drug user, it’s like, they forget about your meds, they are later with you or run to the other patients before they run to you. (P-26)

This participant spoke about how she used the lack of attention to her “advantage” in one of her admissions:

And being at [name of hospital], it’s easy to get away with smoking. Like, I was able to do my drugs, in my room and not get in trouble, so obviously, they were not paying attention to what I was doing. (P-26)

Being ignored had more serious consequences for some participants including the following participant who described the lack of support he received in hospital after overdosing on fentanyl. He was encouraged to go to the hospital but then “when I got there, it’s like, you know, there’s nobody’s treating me or nothing or anything. Like, so, what am I doing here?… It’s like, they didn’t want to help me anyway…” so he left, and overdosed again, this time resulting in a coma:

… cause of the Narcan that they gave, right, I felt like, a dope sickness. Right? So I went and did another fentanyl patch and that was the last thing I remember. And I remember waking up, like, [weeks] later. It was like, quite the experience, you know? (P-33)

Prescribing practices and pain management

Participants felt that their known or suspected drug use strongly impacted physicians’ adjudication for medications and prescribing practices.

Well, they were very cautious about prescribing me anything like Clonazepam or …Oxycontin, because ‘Oh, you are a drug user. We cannot give you that. You might get addicted to it.’ (P-31)

The stigma of being on methadone, you are treated like you are a junkie from the back alleys …So, they do not want to prescribe you anything, or that they make the assumption that you are going to sell it. (P-32)

Participants described significant barriers to pain management. In most instances this resulted in inconsistent and inadequate pain management. One participant spoke about being transferred between hospitals and the challenges she faced maintaining her pain management:

…it was hell getting my pain meds. They were like ‘You’re on forty-five milligrams three times a day? I find that hard to believe.’ […] Once I got given to a surgeon, he was like ‘This is ridiculous. Give this woman some pain medication.’ (P-21)

Participants spoke about choosing to go to one hospital over another because of discrepancies in their experiences (by facility).

I have severe Crohn’s, which is very painful. And, I went in one night, they would not give me painkillers, because I had a red flag on my chart. (P-36)

But, he identified no problems getting pain medication at another hospital where “they know how painful it was… so they know when I go in there, I’m not playing around.”

When adequate pain management was achieved, it was often after significant delay and following strong advocacy efforts, usually by the patients themselves.

Participants felt pain management decisions were not appropriately informed, particularly for those on methadone. They felt decisions were based on presumed drug use and not appropriately informed by clinical acuity, present drug use, drug of choice, or tolerance. The participant below also refers to the issue of inconsistency:

But the hospitals are normally pretty good. But once in a while, you’ll run into, you know, certain doctors there, and they do not want to do nothing for you. Like, I had my jaw busted, and I wanted something to cut through my methadone for pain, right? And I said ‘Well, I am not going to go through with the operation unless you are going to give me something for the pain.’ Like, it’s only something for, while I am in the hospital... And they did not, they did not give me nothing for it. (P-33)

This participant went through with the surgery, without the requested pain medication but later had his girlfriend bring him morphine to address his post-surgical pain.

Another participant recounts her difficulty getting pain medication because of the presumed impact of methadone and the lack of consideration for her tolerance, despite open conversations.

I am on methadone too, so I can see the difference there as well, right? Because when you are on methadone, doctors sometimes do not want to give you any kind of pain relief, even though you could probably take more pain relief than the average person. So I often have to take a letter with me, right? But I bet you if I went to [name of hospital] with that, they would not give me anything. (P-27).

Participants spoke about various approaches for dealing with the challenges of pain management while in hospital. One participant identified a common approach: “You’ve got the power to relieve my pain; I’m going to kiss your ass.” But she states that “I don’t do that”. Instead, she describes her approach: “I told them ‘I’m not up here to jack up your emergency room to give me more opiates. I have my own pain meds. But you gotta let me take them if you’re not going to prescribe them.’ Right?” (P-21). Other approaches included using non-prescribed medications, leaving against medical advice, and strong self-advocacy efforts to negotiate with providers for timely care and adequate pain medication. These are discussed in more detail in the final section.

Impact of care experiences

The negative hospital experiences participants described impacted their strategies for navigating healthcare and their future health seeking.

Strategies for navigating hospital care

Different strategies to navigate care were apparent, as illustrated in the quotes above. Some participants spoke about trying to be a “good patient”, trying to cause as little disruption as possible.

I have had no issues so far. they have been all pretty good. I do not require a lot of medication, or I do not demand a lot… (P-40)

This participant referred to himself as “an easy patient”, not asking “too many questions” because “you don’t want subpar treatment ever, so.” Another participant described being a “good patient” and said he would “go with the flow” and avoid arguing with healthcare providers “cause I know, even if they are rude, I’ll wait it out until I get what I need first. Cause if you don’t, you don’t get what you need” (P-16). Being an easy patient was a strategy informed by past experiences and used to pave the way for future interactions:

I wanted to get high the whole time. … it was just, lack of it [drugs] being there, and I knew that I’d probably end up there [in hospital] again. So you do not want to screw with them too much, where you know, you are going to be [on] file then... I try my best to behave as much as I can. (P-34)

However, others directly confronted clinicians and used their knowledge of the healthcare system to demand care they perceived to be their right.

Okay, I have got to tell you, I do not think I have had a hideous experience in a general hospital. A), I am articulate and know what’s going on. People get bulldozed when they do not say anything. I am too emotional for that. And I cannot let people walk all over me. That does not fly with me. You know? And unfortunately, doctors think they can walk over everybody, and paint everybody with the same brush. When you are dealing with drugs, you cannot do that. (P-21)

With repeated experience in hospital, participants spoke about learning strategies to navigate the healthcare system. One participant indicated that his care changed when he spoke up: “Oh, I mean, I got to the point where I was in the hospital, I told them, I said ‘Either you look after it, or I’m going to get up and I’m going to go out on the street; I’m going to go get my own damn drugs’. And I’m going to look after myself” (P-29). This participant indicated that this was a learned behavior that had been successful on many occasions where with “…such a fuss and so on, that they finally broke down and actually dealt with me. But the point is, do you have to go that far, just to get attended to? I mean, it’s ridiculous that you have to fight that hard.”

Future health seeking

Negative hospital experiences influenced participants’ willingness to navigate services and timeliness of presenting for care with subsequent health issues. One participant recounted why they delayed seeking care in a timely fashion:

I was afraid. I was afraid of, they [hospital staff] would not accept me or they would not like, ‘Oh well, they could tell I am on drugs. they are not going to help me.’ … So I did not go. (P-35)

The act of seeking care when it felt necessary was often delayed when participants were directly under the influence of drugs and feared being judged. As one participant said, “I was just too stoned, and too paranoid to leave the apartment, to actually even call 911 or go to the hospital. And too ashamed.” (P-22). However, this delay in seeking care was further accentuated by past negative experiences.

I wanted to finish doing my drugs before I went to the hospital. (laugh) And then I did not end up going and then that left me sicker. You know? But I did not want the nightmare of [name of hospital]. Right? … It was so powerful, that little threat about no pain meds, once, that they did, that affected my outlook for [name of hospital]. Period. (P-21)

Past experiences influenced what participants were willing to disclose to clinicians but also what care they “bothered” to seek.

You want to be free to tell but you are also afraid to tell them, because then you know they are going to cut you down … you do not want to tell them that ‘Oh yeah, I smoke crack.’ or ‘I do this and I do that.’ because immediately you are screwed. Oh, now you are reduced to Percocets instead. But I need morphine. I do not need Percocets. I need morphine. But try to tell them that, right? And this is what happens. (P-29)

When we asked one participant about how they got pain medication when admitted to hospital, they responded, “I don’t even ask… I’ve tried I don’t know how many times to get, ah, through my own family doctor, walk ins, et cetera, over the years. I don’t even, I don’t even bother. I just buy them.” (P-15)

In some cases, lack of pain medication and poor care led to participants leaving against medical advice. One participant recounted how he was in withdrawal and they refused to give him anything to manage his pain so he “… told them ‘I’m leaving.’ Because I had my [percocets] at home, right?” (which he clarified as “stuff I bought off the street”). He added: “I was scared, because I wasn’t sure whether I should really be doing this [leaving ‘against medical advice’]. But my whole body just ached and the ibuprofen wasn’t doing anything for me.” (P-39)


In this study, we captured in-patient hospital experiences of PWUD living with HIV and/or hepatitis C. While not all experiences were bad, participants described clinicians’ stigma and challenges with achieving access to treatment, including insufficient and unpredictable pain management, which resulted in distrust, use of non-prescribed drugs during admission, decisions to leave against medical advice and delays and anxiety when seeking care in the future. Participants identified behavioral strategies for navigating healthcare and described choosing which hospital to present at based on past experiences.

This study brings depth to our understanding of the patient experience of hospital care for a marginalized population that is associated with frequent and high-cost health system use. Previous research has demonstrated healthcare provider stigma related to drug use and people who use drugs; however, this is most frequently captured from the provider perspective. We identify broad-ranging impacts of drug use, from the patient perspective, on negotiating, navigating and receiving hospital-based care and its recursivity. This study highlights the influence of drug use on the experience of hospital care and engagement in healthcare more broadly.

A narrative review of 158 primary research studies identified stigma towards drug users to be common among the general public and non-specialist professionals. It concluded that the stigmatization has a profound impact on the lives of PWUD including their chances of recovery [19]. A common theme from clinicians was difficult, and in some cases verbally and physically violent, interactions with PWUD. This, coupled with limited education focused on drug use and addiction in clinician training more broadly, likely has a role in the stigmatizing and negative interactions reported by people who use drugs. The review suggested that blaming and stigmatizing behaviors by clinicians “is preventing” people who use drugs “from seeking help for general health problems.” Our findings support this hypothesis, as participants described the impact of negative experiences with healthcare on all stages of accessing and engaging in care.

Hospital-based pain management for PWUD is an identified challenge for both providers and patients [41,42,43,44]. Not all experiences are, as expected, negative, and many PWUD do not report having had challenges with accessing pain management [42]; however, pain management is associated with significant distrust for both providers and patients [45, 46]. Our work supports the work of others in identifying the impact of delayed and inadequate pain management on clinician-patient interactions, decisions to use illicit drugs in hospital [47], decisions to leave hospital before treatment is complete [48], and decisions to seek care. For many in this study, the process of accessing, or being denied, pain management had an overriding impact on the experience of hospital care and decisions regarding engaging in hospital care in the present and the future.

While we intended to focus on recent in-patient hospital experiences, it became apparent that the experiences in the ED, as the place where patients present and are assessed before being admitted, and previous hospital experiences, were critical to our understanding of the in-patient care experience and, thus also, in our opinion, essential for informing strategies to improve care. Individuals’ decisions to present in the ED and negotiate accessing care, and the process of admission, were required steps in the journey of acute care and set the stage for participants’ experiences of care during an admission. Our work echoes calls for greater attention and support for addiction service provision in emergency departments [49,50,51]. Future research and interventions to improve the health and care of PWUDs should explore and consider not just experiences of accessing and receiving care, but also conceptions of healthcare, health seeking behaviors, and dynamic relationships within healthcare for PWUDs. Our findings also support calls for integrated care, where multiple services are provided in the same facility, enabling a more accessible and comprehensive approach to complex patients [52, 53]. Additional research and interventions may benefit by strengthening hospital-community relationships (see for example [54, 55]), impacting, on a systems level, the required steps and work necessary for PWUDs to navigate and initially present for healthcare. Interventions may include opportunities to move care out of the hospital, where possible, as one approach in a comprehensive strategy to address structural barriers.

This study has limitations that should inform its interpretation and next steps. Firstly, we recruited individuals who self-identified as using drugs from two urban settings in Ontario, Canada. The social, political, and structural context greatly influence all stages of accessing and receiving care and the impact of drug use and should be considered when exploring the applicability of these findings to other contexts. Even in these same cities, the context of the current opioid crisis has likely directly and indirectly influenced patient experiences with emergency medical services and emergency departments (since this study) for those who use, or are presumed to use, drugs. However, there is no evidence to suggest that the issues identified here are any less significant, but addressing them may be more pressing in light of increasing numbers of overdoses and hospitalizations related to opioid-related harms [56, 57]. We also focused on PWUDs who were also living with HIV and/or HCV. The demographics of our study population, while relatively representative (in terms of age and gender distribution) of people living with HIV in the province, did not capture the experiences of young adults and only 25% of our participants were women. This group of adults living with HIV/HCV likely represents a more complex and high-intensity healthcare using population of PWUDs. Interestingly, descriptions and understandings of their experiences primarily related to substance use and did not generally relate to HIV- and HCV-specific issues or conditions suggesting the themes may be relevant to the broader population of PWUD. It is also important to highlight that inclusion for this study required identification of the use of any illicit substance or the use of opioids without a prescription (the majority of participants reported poly-substance use); we did not select by, or capture, routes of administration. We were unable to explore the impact of drug use on hospital care experience by type, frequency, and patterns of drug use but expect that there are important relationships to consider.

In conclusion, this study captures the impact of drug use on hospital care from the experiences of patients. Improving the care experiences of people who use drugs may significantly improve their engagement in care and illness management [54, 58, 59]. Our findings illustrate that drug use can impact all stages of hospital care, identifying the need for it, seeking, negotiating, and engaging in it. This understanding can be helpful for both expanding and focusing our attention to the various essential steps in accessing and receiving appropriate healthcare for PWUD. We must address the issues of stigma and inconsistency of access to care, and recognize the resulting work and strategies adopted by patients to navigate the system. Perhaps most importantly, we must improve our consistency and approach to pain management for people who use drugs and understand the inter-connections between negotiating pain management and engaging in other healthcare during a hospital admission and in the future.


  1. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–86.

    Article  PubMed  Google Scholar 

  2. Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1564–74.

    Article  PubMed  Google Scholar 

  3. Ahmad KA. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1603–58.

    Article  Google Scholar 

  4. Hope V, Parry J, Ncube F, Hickman M. Not in the vein:‘missed hits’, subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom. Int J Drug Policy. 2016;28:83–90.

    Article  CAS  PubMed  Google Scholar 

  5. Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug & Alcohol Dependence. 2017;171:39–49.

    Article  Google Scholar 

  6. Cheatle MD. Prescription opioid misuse, abuse, morbidity, and mortality: balancing effective pain management and safety. Pain Medicine. 2015;16(suppl_1):S3–8.

    Article  PubMed  Google Scholar 

  7. McNeil R, Kerr T, Lampkin H, Small W. “We need somewhere to smoke crack”: an ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada. Int J Drug Policy. 2015;26(7):645–52.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797–808.

    Article  PubMed  Google Scholar 

  9. Degenhardt L, Mathers BM, Wirtz AL, Wolfe D, Kamarulzaman A, Carrieri MP, et al. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010–2012? A review of the six highest burden countries. Int J Drug Policy. 2014;25(1):53–60.

    Article  PubMed  Google Scholar 

  10. Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(12):1385–98.

    Article  PubMed  Google Scholar 

  11. Fairbairn N, Milloy M-J, Zhang R, Lai C, Grafstein E, Kerr T, et al. Emergency department utilization among a cohort of HIV-positive injecting drug users in a Canadian setting. J Emerg Med. 2012;43(2):236–43.

    Article  PubMed  Google Scholar 

  12. Thakarar K, Morgan JR, Gaeta JM, Hohl C, Drainoni M-L. Predictors of frequent emergency room visits among a homeless population. PLoS One. 2015;10(4):e0124552.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Hardy M, Cho A, Stavig A, Bratcher M, Dillard J, Greenblatt L, et al. Understanding frequent emergency department use among primary care patients. Population health management. 2018;21(1):24–31.

    Article  PubMed  Google Scholar 

  14. Doupe MB, Palatnick W, Day S, Chateau D, Soodeen R-A, Burchill C, et al. Frequent users of emergency departments: developing standard definitions and defining prominent risk factors. Ann Emerg Med. 2012;60(1):24–32.

    Article  PubMed  Google Scholar 

  15. Suárez-García I, Sobrino-Vegas P, Dalmau D, Rubio R, Iribarren JA, Blanco JR, et al. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality. Addiction. 2016;111(7):1235–45.

    Article  PubMed  Google Scholar 

  16. de Coul ELO, Van Sighem A, Brinkman K, van Benthem BH, van der Ende ME, Geerlings S, et al. Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996–2014: results from a national observational cohort. BMJ Open. 2016;6(1):e009688.

    Article  Google Scholar 

  17. Owens PL, Mutter R, Stocks C. Mental health and substance abuse-related emergency department visits among adults, 2007: statistical brief# 92; 2006.

    Google Scholar 

  18. Day C, Ross J, Dolan K. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination? Drug Alcohol Rev. 2003;22(3):317–21.

    Article  PubMed  Google Scholar 

  19. Lloyd C. The stigmatization of problem drug users: a narrative literature review. Drugs: education, prevention and policy. 2013;20(2):85–95.

    Google Scholar 

  20. Mincin J. Addiction and stigmas: overcoming labels, empowering people. New directions in treatment, education, and outreach for mental health and addiction. Cham: Springer; 2018. p. 125–31.

  21. Kinsler JJ, Wong MD, Sayles JN, Davis C, Cunningham WE. The effect of perceived stigma from a healthcare provider on access to care among a low-income HIV-positive population. AIDS Patient Care STDs. 2007;21(8):584–92.

    Article  PubMed  Google Scholar 

  22. Haber PS, Demirkol A, Lange K, Murnion B. Management of injecting drug users admitted to hospital. Lancet. 2009;374(9697):1284–93.

    Article  PubMed  Google Scholar 

  23. Miller NS, Sheppard LM, Colenda CC, Magen J. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Acad Med. 2001;76(5):410–8.

    Article  CAS  PubMed  Google Scholar 

  24. Ford R. Interpersonal challenges as a constraint on care: the experience of nurses’ care of patients who use illicit drugs. Contemp Nurse. 2011;37(2):241–52.

    Article  PubMed  Google Scholar 

  25. Kraut A, Fransoo R, Olafson K, Ramsey CD, Yogendran M, Garland A. A population-based analysis of leaving the hospital against medical advice: incidence and associated variables. BMC Health Serv Res. 2013;13(1):415.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Choi M, Kim H, Qian H, Palepu A. Readmission rates of patients discharged against medical advice: a matched cohort study. PLoS One. 2011;6(9):e24459.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Yong T, Fok J, Hakendorf P, Ben-Tovim D, Thompson C, Li J. Characteristics and outcomes of discharges against medical advice among hospitalised patients. Intern Med J. 2013;43(7):798–802.

    Article  CAS  PubMed  Google Scholar 

  28. Ti L, Ti L. Leaving the hospital against medical advice among people who use illicit drugs: a systematic review. Am J Public Health. 2015;105(12):e53–e9.

    Article  PubMed  PubMed Central  Google Scholar 

  29. McNeil R, Small W, Wood E, Kerr T. Hospitals as a ‘risk environment’: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc Sci Med. 2014;105:59–66.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Bachhuber MA, Southern WN. Hospitalization rates of people living with HIV in the United States, 2009. Public Health Rep. 2014;129(2):178–86.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ng R, Kendall CE, Burchell AN, Bayoumi AM, Loutfy MR, Raboud J, et al. Emergency department use by people with HIV in Ontario: a population-based cohort study. CMAJ open. 2016;4(2):E240.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Teshale E, Xing J, Moorman A, Holmberg S, Spradling P, Gordon S, et al. Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CH e CS), 2006–2013. J Viral Hepat. 2016;23(10):748–54.

    Article  CAS  PubMed  Google Scholar 

  33. Sandelowski M. Whatever happened to qualitative description? Research in nursing & health. 2000;23(4):334–40.

    Article  CAS  Google Scholar 

  34. Sandelowski M. What's in a name? Qualitative description revisited. Research in nursing & health. 2010;33(1):77–84.

    Google Scholar 

  35. Switzer S, Guta A, de Prinse K, Chan Carusone S, Strike C. Visualizing harm reduction: methodological and ethical considerations. Soc Sci Med. 2015;133:77–84.

    Article  CAS  PubMed  Google Scholar 

  36. Strike C, Guta A, de Prinse K, Switzer S, Chan CS. Living with addiction: the perspectives of drug using and non-using individuals about sharing space in a hospital setting. Int J Drug Policy. 2014;25(3):640–9.

    Article  CAS  PubMed  Google Scholar 

  37. Switzer S, Carusone SC, Guta A, Strike C. “Doing a little activity like this, opens it up”: lessons learned from conducting a flexible, activity-based community advisory committee. Qual Health Res in press.

  38. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.

    Article  Google Scholar 

  39. Pawson R, Manzano-Santaella A. A realist diagnostic workshop. Evaluation. 2012;18(2):176–91.

    Article  Google Scholar 

  40. Koelsch LE. Reconceptualizing the member check interview. Int J Qual Methods. 2013;12(1):168–79.

    Article  Google Scholar 

  41. McCreaddie M, Lyons I, Watt D, Ewing E, Croft J, Smith M, et al. Routines and rituals: a grounded theory of the pain management of drug users in acute care settings. J Clin Nurs. 2010;19(19–20):2730–40.

    Article  PubMed  Google Scholar 

  42. Blay N, Glover S, Bothe J, Lee S, Lamont F. Substance users’ perspective of pain management in the acute care environment. Contemp Nurse. 2012;42(2):289–97.

    Article  PubMed  Google Scholar 

  43. Berg KM, Arnsten JH, Sacajiu G, Karasz A. Providers’ experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med. 2009;24(4):482–8.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Baldacchino A, Gilchrist G, Fleming R, Bannister J. Guilty until proven innocent: a qualitative study of the management of chronic non-cancer pain among patients with a history of substance abuse. Addict Behav. 2010;35(3):270–2.

    Article  PubMed  Google Scholar 

  45. Krokmyrdal KA, Andenæs R. Nurses’ competence in pain management in patients with opioid addiction: a cross-sectional survey study. Nurse Educ Today. 2015;35(6):789–94.

    Article  PubMed  Google Scholar 

  46. Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users. J Gen Intern Med. 2002;17(5):327–33.

    PubMed  PubMed Central  Google Scholar 

  47. Ti L, Voon P, Dobrer S, Montaner J, Wood E, Kerr T. Denial of pain medication by healthcare providers predicts in-hospital illicit drug use among individuals who use illicit drugs. Pain Research and Management. 2015;20(2):84–8.

    Article  PubMed  Google Scholar 

  48. Ti L, Milloy M, Buxton J, McNeil R, Dobrer S, Hayashi K, et al. Factors associated with leaving hospital against medical advice among people who use illicit drugs in Vancouver, Canada. PloS one. 2015;10(10):e0141594.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Clarke DE, Dusome D, Hughes L. Emergency department from the mental health client’s perspective. Int J Ment Health Nurs. 2007;16(2):126–31.

    Article  PubMed  Google Scholar 

  50. Weiland TJ, Mackinlay C, Hill N, Gerdtz MF, Jelinek GA. Optimal management of mental health patients in Australian emergency departments: barriers and solutions. Emergency Medicine Australasia. 2011;23(6):677–88.

    Article  PubMed  Google Scholar 

  51. Wise-Harris D, Pauly D, Kahan D, de Bibiana JT, Hwang SW, Stergiopoulos V. “Hospital was the only option”: experiences of frequent emergency department users in mental health. Adm Policy Ment Health Ment Health Serv Res. 2017;44(3):405–12.

    Article  Google Scholar 

  52. Collins AB, Parashar S, Hogg RS, Fernando S, Worthington C, McDougall P, et al. Integrated HIV care and service engagement among people living with HIV who use drugs in a setting with a community-wide treatment as prevention initiative: a qualitative study in Vancouver, Canada. J Int AIDS Soc. 2017;20(1):21407.

  53. Ti L, Milloy M-J, Turje RB, Montaner J, Wood E, Kerr T. The impact of an HIV/AIDS adult integrated health program on leaving hospital against medical advice among HIV-positive people who use illicit drugs. J Public Health. 2016;39(2):e33–e9.

    Google Scholar 

  54. Jafari S, Joe R, Elliot D, Nagji A, Hayden S, Marsh DC. A community care model of intravenous antibiotic therapy for injection drug users with deep tissue infection for “reduce leaving against medical advice”. Int J Ment Heal Addict. 2015;13(1):49–58.

    Article  Google Scholar 

  55. Voon P, Joe R, Fairgrieve C, Ahamad K. Treatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV. BMJ case reports. 2016;2016:bcr2016215557.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. Measuring the burden of opioid-related mortality in Ontario, Canada. J Addict Med. 2018;12(5):418.

    Article  PubMed  PubMed Central  Google Scholar 

  57. O’Connor S, Grywacheski V, Louie K. Hospitalizations and emergency department visits due to opioid poisoning in Canada. Health Promot Chronic Dis Prev Canada: Research, Policy & Practice. 2018;38(6):244–7.

  58. Small W, Milloy M, McNeil R, Maher L, Kerr T. Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study. AIDS Res Ther. 2016;13(1):26.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989:S110–S27.

Download references


We would like to acknowledge the participants involved in this study for sharing their experiences. We thank clients at Casey House and the AIDS Committee of Ottawa for advising on this project and staff for helping facilitate engagement in the study.


This work was supported by the Ontario HIV Treatment Network (OHTN) under the Community Based Research Grant #1035.

Availability of data and materials

The data generated and analysed during this study are not currently available. There is potential for availability of data with approval by all relevant organizations’ research ethics committees.

Author information

Authors and Affiliations



SCC, CS, and AG were co-leads on the study, from conception to completion. SR, AG, and SCC conducted participant interviews. SCC, supported by CS and AG and with feedback by all other authors, led the analysis and writing of this paper. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Carol Strike.

Ethics declarations

Ethics approval and consent to participate

This study was reviewed and approved by the HIV Research Ethics Board at the University of Toronto. All participants provided informed, written consent prior to participation.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chan Carusone, S., Guta, A., Robinson, S. et al. “Maybe if I stop the drugs, then maybe they’d care?”—hospital care experiences of people who use drugs. Harm Reduct J 16, 16 (2019).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: